Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
3.930
+0.270 (7.38%)
Nov 21, 2024, 3:02 PM EST - Market closed
Titan Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 4.09 | 6.76 | 2.94 | 6.04 | 5.41 | 5.22 | Upgrade
|
| Cash & Short-Term Investments | 4.09 | 6.76 | 2.94 | 6.04 | 5.41 | 5.22 | Upgrade
|
| Cash Growth | 3797.14% | 130.17% | -51.35% | 11.53% | 3.64% | -43.81% | Upgrade
|
| Accounts Receivable | 0.04 | 0.05 | 0.04 | 0.11 | 0.88 | 0.44 | Upgrade
|
| Receivables | 0.04 | 1.05 | 0.04 | 0.11 | 0.88 | 0.44 | Upgrade
|
| Inventory | - | - | 0.11 | 0.29 | 0.33 | 0.56 | Upgrade
|
| Prepaid Expenses | 0.22 | 0.2 | 0.31 | 0.48 | 0.52 | 0.53 | Upgrade
|
| Restricted Cash | - | 0.01 | 0.2 | 0.3 | - | - | Upgrade
|
| Other Current Assets | - | - | 0.01 | 0.01 | 0.18 | 1.55 | Upgrade
|
| Total Current Assets | 4.35 | 8.02 | 3.6 | 7.23 | 7.33 | 8.31 | Upgrade
|
| Property, Plant & Equipment | - | 0.07 | 0.41 | 0.72 | 0.76 | 1.21 | Upgrade
|
| Other Long-Term Assets | - | - | 0.05 | 0.05 | - | - | Upgrade
|
| Total Assets | 4.35 | 8.09 | 4.06 | 7.99 | 8.09 | 9.52 | Upgrade
|
| Accounts Payable | 0.36 | 0.35 | 0.7 | 0.8 | 1.25 | 0.82 | Upgrade
|
| Accrued Expenses | - | 0.52 | 1.49 | 0.32 | 0.53 | 0.43 | Upgrade
|
| Short-Term Debt | - | 0.5 | - | - | - | - | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.33 | - | Upgrade
|
| Current Portion of Leases | - | 0.07 | 0.12 | 0.11 | 0.15 | 0.27 | Upgrade
|
| Current Unearned Revenue | - | 0.01 | 0.2 | 0.3 | - | - | Upgrade
|
| Other Current Liabilities | - | - | 0.13 | 1.14 | 1.96 | 2.08 | Upgrade
|
| Total Current Liabilities | 0.36 | 1.44 | 2.63 | 2.67 | 4.22 | 3.6 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.33 | 4.02 | Upgrade
|
| Long-Term Leases | - | - | 0.07 | 0.19 | - | 0.15 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.32 | Upgrade
|
| Total Liabilities | 0.36 | 1.44 | 2.7 | 2.86 | 4.56 | 8.09 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | 0 | Upgrade
|
| Additional Paid-In Capital | 398.98 | 398.47 | 387.62 | 381.18 | 370.8 | 350.47 | Upgrade
|
| Retained Earnings | -394.98 | -391.83 | -386.26 | -376.06 | -367.28 | -349.04 | Upgrade
|
| Total Common Equity | 3.99 | 6.64 | 1.36 | 5.14 | 3.53 | 1.43 | Upgrade
|
| Shareholders' Equity | 3.99 | 6.64 | 1.36 | 5.14 | 3.53 | 1.43 | Upgrade
|
| Total Liabilities & Equity | 4.35 | 8.09 | 4.06 | 7.99 | 8.09 | 9.52 | Upgrade
|
| Total Debt | - | 0.57 | 0.19 | 0.3 | 0.81 | 4.44 | Upgrade
|
| Net Cash (Debt) | 4.09 | 6.2 | 2.75 | 5.74 | 4.6 | 0.78 | Upgrade
|
| Net Cash Growth | - | 125.27% | -52.07% | 24.63% | 488.75% | -84.30% | Upgrade
|
| Net Cash Per Share | 5.00 | 8.24 | 4.09 | 11.79 | 24.40 | 20.42 | Upgrade
|
| Filing Date Shares Outstanding | 0.91 | 0.91 | 0.75 | 0.6 | 0.49 | 0.16 | Upgrade
|
| Total Common Shares Outstanding | 0.91 | 0.78 | 0.75 | 0.5 | 0.36 | 0.1 | Upgrade
|
| Working Capital | 3.99 | 6.57 | 0.97 | 4.56 | 3.11 | 4.71 | Upgrade
|
| Book Value Per Share | 4.37 | 8.50 | 1.82 | 10.36 | 9.89 | 14.98 | Upgrade
|
| Tangible Book Value | 3.99 | 6.64 | 1.36 | 5.14 | 3.53 | 1.43 | Upgrade
|
| Tangible Book Value Per Share | 4.37 | 8.50 | 1.82 | 10.36 | 9.89 | 14.98 | Upgrade
|
| Machinery | - | 0.71 | 1.82 | 1.82 | 2.76 | 5.02 | Upgrade
|
| Construction In Progress | - | - | - | - | - | 0.07 | Upgrade
|
| Leasehold Improvements | - | - | - | - | 0.41 | 0.41 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.